PACIFIC-DRILLING
13.8.2019 00:14:13 CEST | Business Wire | Press release
Pacific Drilling S.A. (NYSE: PACD) (“Pacific Drilling” or the “Company”) today reported results for the second quarter of 2019. Net loss for second-quarter 2019 was $73.6 million or $0.98 per diluted share, compared to net loss of $84.0 million or $1.12 per diluted share in first-quarter 2019. EBITDA(a) for second-quarter 2019 was $14.0 million, compared to $1.9 million in first-quarter 2019.
“During the second quarter, we maintained our focus on putting rigs to work while delivering improved revenue and EBITDA compared to the first quarter. We added backlog for our fleet as an option was exercised for Pacific Santa Ana . The ramp-up of Pacific Khamsin , in preparation for its contract with Equinor, remains on schedule for start of operations in November,” said CEO Bernie Wolford.
“The market for deepwater drilling continues to show signs of gradual strengthening as both the pace and number of new fixtures improved during the second quarter. We also saw customers moving beyond the spot market to consider more substantial drilling campaigns, including tenders for programs with one or more year terms. In particular, the Gulf of Mexico is showing signs of improving demand, especially in Mexico, as operators are approaching their lease commitment-well deadlines.”
Second-Quarter 2019 Operational and Financial Commentary
Second-quarter 2019 contract drilling revenue was $76.4 million, which included $3.8 million in reimbursable revenue. This compared to first-quarter 2019 contract drilling revenue of $65.9 million, which included $3.4 million in reimbursable revenue. The increase in revenue resulted primarily from the Pacific Santa Ana commencing operations with Total in Senegal.
Operating expenses were $52.3 million for both second-quarter 2019 and first-quarter 2019.
General and administrative expenses for the second-quarter of 2019 were $10.0 million, as compared to $11.2 million for the first-quarter of 2019. The decrease in general and administrative expenses was primarily due to the impact of cost control and process optimization initiatives implemented during the first quarter of 2019.
Adjusted EBITDA(a) for second-quarter 2019 was $15.6 million, compared to $4.3 million in first-quarter 2019.
Capital expenditures for the second-quarter of 2019 were $3.8 million compared to $17.6 million in the first-quarter of 2019.
Footnotes
| (a) | EBITDA and Adjusted EBITDA are non-GAAP financial measures. For a definition of EBITDA and Adjusted EBITDA and a reconciliation to net loss, please refer to the schedule included in this release. Management uses this operational metric to track company results and believes that this measure provides additional information that highlights the impact of our operating efficiency as well as the operating and support costs incurred in achieving the revenue performance. |
2019 Guidance
A schedule of Pacific Drilling’s updated 2019 guidance as of August 12, 2019 is available in the “Quarterly and Annual Results” subsection of the “Investor Relations” section of our website, www.pacificdrilling.com .
Conference Call
Pacific Drilling will conduct a conference call at 10 a.m. Central time on Tuesday, August 13, 2019 to discuss second-quarter 2019 results. To access the conference call, participants should contact the Conference Call Operator at +1 800-353-6461 within North America or +1 334-323-0501 outside of North America approximately 10 minutes prior to the scheduled start time and provide confirmation code #8853719. On the following day a replay of the call will be available on the company’s website or by dialing +1 888-203-1112 within North America or +1 719-457-0820 outside of North America and providing confirmation code #8853719.
About Pacific Drilling
With its best-in-class drillships and highly experienced team, Pacific Drilling is committed to becoming the industry’s preferred high-specification, deepwater drilling contractor. Pacific Drilling’s fleet of seven drillships represents one of the youngest and most technologically advanced fleets in the world. Pacific Drilling has principal offices in Luxembourg and Houston. For more information about Pacific Drilling, including our current Fleet Status, please visit our website at www.pacificdrilling.com .
Forward-Looking Statements
Certain statements and information contained in this press release constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and are generally identifiable by their use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “intend,” “our ability to,” “may,” “plan,” “potential,” “predict,” “project,” “projected,” “should,” “will,” “would”, or other similar words which are not generally historical in nature. The forward-looking statements speak only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise.
Our forward-looking statements express our current expectations or forecasts of possible future results or events, including future financial and operational performance and cash balances; revenue efficiency levels; market outlook; forecasts of trends; future client contract opportunities; future contract dayrates; our business strategies and plans or objectives of management; estimated duration of client contracts; backlog; expected capital expenditures; projected costs and savings; and the potential impact of our completed Chapter 11 proceedings on our future operations and ability to finance our business.
Although we believe that the assumptions and expectations reflected in our forward-looking statements are reasonable and made in good faith, these statements are not guarantees, and actual future results may differ materially due to a variety of factors. These statements are subject to a number of risks and uncertainties and are based on a number of judgments and assumptions as of the date such statements are made about future events, many of which are beyond our control. Actual events and results may differ materially from those anticipated, estimated, projected or implied by us in such statements due to a variety of factors, including if one or more of these risks or uncertainties materialize, or if our underlying assumptions prove incorrect.
Important factors that could cause actual results to differ materially from our expectations include: the global oil and gas market and its impact on demand for our services; the offshore drilling market, including reduced capital expenditures by our clients; changes in worldwide oil and gas supply and demand; rig availability and supply and demand for high-specification drillships and other drilling rigs competing with our fleet; our ability to enter into and negotiate favorable terms for new drilling contracts or extensions; our ability to successfully negotiate and consummate definitive contracts and satisfy other customary conditions with respect to letters of intent and letters of award that we receive for our drillships; possible cancellation, renegotiation, termination or suspension of drilling contracts as a result of mechanical difficulties, performance, market changes or other reasons; costs related to stacking of rigs; downtime and other risks associated with offshore rig operations, including unscheduled repairs or maintenance, relocations, severe weather or hurricanes; our small fleet and reliance on a limited number of clients; our ability to execute our business plans; the effects of our completed Chapter 11 proceedings on our future operations; and the other risk factors described in our 2018 Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 12, 2019 and our Reports on Form 6-K. These documents are available through our website at www.pacificdrilling.com or through the SEC’s website at www.sec.gov .
PACIFIC DRILLING S.A. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (in thousands, except per share information) (unaudited) |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
|
Predecessor |
|
Successor |
|
|
Predecessor |
|||||||
|
|
Three Months |
|
Three Months |
|
|
Three Months |
|
Six Months |
|
|
Six Months |
|||||
|
|
Ended June 30, |
|
Ended March 31, |
|
|
Ended June 30, |
|
Ended June 30, |
|
|
Ended June 30, |
|||||
|
|
2019 |
|
2019 |
|
|
2018 |
|
2019 |
|
|
2018 |
|||||
Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract drilling |
|
$ |
76,415 |
|
$ |
65,916 |
|
|
$ |
66,564 |
|
$ |
142,331 |
|
|
$ |
148,633 |
Costs and expenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses |
|
|
(52,254) |
|
|
(52,296) |
|
|
|
(55,968) |
|
|
(104,550) |
|
|
|
(120,322) |
General and administrative expenses |
|
|
(10,010) |
|
|
(11,246) |
|
|
|
(12,881) |
|
|
(21,256) |
|
|
|
(30,085) |
Depreciation and amortization expense |
|
|
(59,330) |
|
|
(58,899) |
|
|
|
(70,070) |
|
|
(118,229) |
|
|
|
(139,990) |
|
|
|
(121,594) |
|
|
(122,441) |
|
|
|
(138,919) |
|
|
(244,035) |
|
|
|
(290,397) |
Operating loss |
|
|
(45,179) |
|
|
(56,525) |
|
|
|
(72,355) |
|
|
(101,704) |
|
|
|
(141,764) |
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(24,406) |
|
|
(24,039) |
|
|
|
(17,211) |
|
|
(48,445) |
|
|
|
(32,140) |
Reorganization items |
|
|
(878) |
|
|
(1,003) |
|
|
|
(13,477) |
|
|
(1,881) |
|
|
|
(25,509) |
Interest income |
|
|
1,665 |
|
|
1,972 |
|
|
|
912 |
|
|
3,637 |
|
|
|
1,700 |
Equity earnings in unconsolidated subsidiaries |
|
|
(263) |
|
|
(1,052) |
|
|
|
— |
|
|
(1,315) |
|
|
|
— |
Expenses to unconsolidated subsidiaries, net |
|
|
(437) |
|
|
(272) |
|
|
|
— |
|
|
(709) |
|
|
|
— |
Other expense |
|
|
(220) |
|
|
(91) |
|
|
|
(1,135) |
|
|
(311) |
|
|
|
(1,330) |
Loss before income taxes |
|
|
(69,718) |
|
|
(81,010) |
|
|
|
(103,266) |
|
|
(150,728) |
|
|
|
(199,043) |
Income tax expense |
|
|
(3,868) |
|
|
(2,969) |
|
|
|
(478) |
|
|
(6,837) |
|
|
|
(752) |
Net loss |
|
$ |
(73,586) |
|
$ |
(83,979) |
|
|
$ |
(103,744) |
|
$ |
(157,565) |
|
|
$ |
(199,795) |
Loss per common share, basic |
|
$ |
(0.98) |
|
$ |
(1.12) |
|
|
$ |
(4.86) |
|
$ |
(2.10) |
|
|
$ |
(9.36) |
Weighted average shares outstanding, basic |
|
|
75,001 |
|
|
75,031 |
|
|
|
21,366 |
|
|
75,016 |
|
|
|
21,352 |
Loss per common share, diluted |
|
$ |
(0.98) |
|
$ |
(1.12) |
|
|
$ |
(4.86) |
|
$ |
(2.10) |
|
|
$ |
(9.36) |
Weighted average shares outstanding, diluted |
|
|
75,001 |
|
|
75,031 |
|
|
|
21,366 |
|
|
75,016 |
|
|
|
21,352 |
PACIFIC DRILLING S.A. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (in thousands) (unaudited) |
|||||||||
|
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
March 31, |
|
December 31, |
|||
|
|
2019 |
|
2019 |
|
2018 |
|||
Assets: |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
305,488 |
|
$ |
337,173 |
|
$ |
367,577 |
Restricted cash |
|
|
8,500 |
|
|
16,965 |
|
|
21,498 |
Accounts receivable, net |
|
|
65,403 |
|
|
46,895 |
|
|
40,549 |
Other receivable |
|
|
28,000 |
|
|
28,000 |
|
|
28,000 |
Materials and supplies |
|
|
42,441 |
|
|
40,598 |
|
|
40,429 |
Prepaid expenses and other current assets |
|
|
14,916 |
|
|
16,390 |
|
|
9,149 |
Total current assets |
|
|
464,748 |
|
|
486,021 |
|
|
507,202 |
Property and equipment, net |
|
|
1,878,848 |
|
|
1,901,540 |
|
|
1,915,172 |
Receivable from unconsolidated subsidiaries |
|
|
204,790 |
|
|
204,790 |
|
|
204,790 |
Intangible asset |
|
|
20,640 |
|
|
53,025 |
|
|
85,053 |
Investment in unconsolidated subsidiaries |
|
|
11,234 |
|
|
11,264 |
|
|
11,876 |
Other assets |
|
|
30,014 |
|
|
29,630 |
|
|
24,120 |
Total assets |
|
$ |
2,610,274 |
|
$ |
2,686,270 |
|
$ |
2,748,213 |
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ equity: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
17,835 |
|
$ |
13,072 |
|
$ |
14,941 |
Accrued expenses |
|
|
18,327 |
|
|
17,716 |
|
|
25,744 |
Accrued interest |
|
|
15,703 |
|
|
32,279 |
|
|
16,576 |
Deferred revenue, current |
|
|
1,298 |
|
|
1,443 |
|
|
— |
Total current liabilities |
|
|
53,163 |
|
|
64,510 |
|
|
57,261 |
Long-term debt |
|
|
1,056,037 |
|
|
1,047,431 |
|
|
1,039,335 |
Payable to unconsolidated subsidiaries |
|
|
3,741 |
|
|
4,381 |
|
|
4,400 |
Other long-term liabilities |
|
|
33,528 |
|
|
34,228 |
|
|
28,259 |
Total liabilities |
|
|
1,146,469 |
|
|
1,150,550 |
|
|
1,129,255 |
Shareholders’ equity: |
|
|
|
|
|
|
|
|
|
Common shares |
|
|
750 |
|
|
750 |
|
|
750 |
Additional paid-in capital |
|
|
1,648,756 |
|
|
1,646,557 |
|
|
1,645,692 |
Treasury shares, at cost |
|
|
(652) |
|
|
(124) |
|
|
— |
Accumulated deficit |
|
|
(185,049) |
|
|
(111,463) |
|
|
(27,484) |
Total shareholders’ equity |
|
|
1,463,805 |
|
|
1,535,720 |
|
|
1,618,958 |
Total liabilities and shareholders’ equity |
|
$ |
2,610,274 |
|
$ |
2,686,270 |
|
$ |
2,748,213 |
PACIFIC DRILLING S. A. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) |
|||||||
|
|
|
|
|
|
|
|
|
|
Successor |
|
|
Predecessor |
||
|
|
Six Months |
|
|
Six Months |
||
|
|
Ended June 30, |
|
|
Ended June 30, |
||
|
|
2019 |
|
|
2018 |
||
|
|
|
|
|
|
|
|
Cash flow from operating activities: |
|
|
|
|
|
|
|
Net loss |
|
$ |
(157,565) |
|
|
$ |
(199,795) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
118,229 |
|
|
|
139,990 |
Amortization of deferred revenue |
|
|
(1,146) |
|
|
|
(12,003) |
Amortization of deferred costs |
|
|
586 |
|
|
|
9,261 |
Amortization of debt premium, net |
|
|
(221) |
|
|
|
— |
Interest paid-in-kind |
|
|
16,923 |
|
|
|
— |
Deferred income taxes |
|
|
4,760 |
|
|
|
(2,408) |
Share-based compensation expense |
|
|
3,064 |
|
|
|
1,171 |
Reorganization items |
|
|
— |
|
|
|
6,877 |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
Accounts receivable |
|
|
(24,854) |
|
|
|
3,316 |
Materials and supplies |
|
|
(2,012) |
|
|
|
1,955 |
Prepaid expenses and other assets |
|
|
(15,229) |
|
|
|
3,871 |
Accounts payable and accrued expenses |
|
|
3,155 |
|
|
|
(19,039) |
Deferred revenue |
|
|
2,444 |
|
|
|
(481) |
Net cash used in operating activities |
|
|
(51,866) |
|
|
|
(67,285) |
Cash flow from investing activities: |
|
|
|
|
|
|
|
Capital expenditures |
|
|
(21,454) |
|
|
|
(10,788) |
Net cash used in investing activities |
|
|
(21,454) |
|
|
|
(10,788) |
Cash flow from financing activities: |
|
|
|
|
|
|
|
Payments for shares issued under share-based compensation plan |
|
|
— |
|
|
|
(4) |
Payments for financing costs |
|
|
(1,115) |
|
|
|
— |
Purchases of treasury shares |
|
|
(652) |
|
|
|
— |
Net cash used in financing activities |
|
|
(1,767) |
|
|
|
(4) |
Net decrease in cash and cash equivalents |
|
|
(75,087) |
|
|
|
(78,077) |
Cash, cash equivalents and restricted cash, beginning of period |
|
|
389,075 |
|
|
|
317,448 |
Cash, cash equivalents and restricted cash, end of period |
|
$ |
313,988 |
|
|
$ |
239,371 |
EBITDA and Adjusted EBITDA Reconciliation
EBITDA is defined as earnings before interest expense, taxes, depreciation and amortization. Adjusted EBITDA is defined as earnings before interest expense, taxes, depreciation, amortization, equity earnings in unconsolidated subsidiaries, expenses to unconsolidated subsidiaries, net and reorganization items. EBITDA and Adjusted EBITDA do not represent and should not be considered an alternative to net income, operating income, cash flow from operations or any other measure of financial performance presented in accordance with U.S. generally accepted accounting principles (“GAAP”) and our calculation of EBITDA and Adjusted EBITDA may not be comparable to that reported by other companies. EBITDA and Adjusted EBITDA are included herein because they are used by management to measure the Company’s operations. Management believes that EBITDA and Adjusted EBITDA present useful information to investors regarding the Company’s operating performance.
PACIFIC DRILLING S.A. AND SUBSIDIARIES
Supplementary Data—Reconciliation of Net Loss to Non-GAAP EBITDA and Adjusted EBITDA (in thousands) (unaudited) |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Successor |
|
|
Predecessor |
|
Successor |
|
|
Predecessor |
|||||||
|
|
Three Months |
|
Three Months |
|
|
Three Months |
|
Six Months |
|
|
Six Months |
|||||
|
|
Ended |
|
Ended |
|
|
Ended |
|
Ended |
|
|
Ended |
|||||
|
|
June 30, |
|
March 31, |
|
|
June 30, |
|
June 30, |
|
|
June 30, |
|||||
|
|
2019 |
|
2019 |
|
|
2018 |
|
2019 |
|
|
2018 |
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(73,586) |
|
$ |
(83,979) |
|
|
$ |
(103,744) |
|
$ |
(157,565) |
|
|
$ |
(199,795) |
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
24,406 |
|
|
24,039 |
|
|
|
17,211 |
|
|
48,445 |
|
|
|
32,140 |
Depreciation and amortization expense |
|
|
59,330 |
|
|
58,899 |
|
|
|
70,070 |
|
|
118,229 |
|
|
|
139,990 |
Income tax expense |
|
|
3,868 |
|
|
2,969 |
|
|
|
478 |
|
|
6,837 |
|
|
|
752 |
EBITDA |
|
$ |
14,018 |
|
$ |
1,928 |
|
|
$ |
(15,985) |
|
$ |
15,946 |
|
|
$ |
(26,913) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity earnings in unconsolidated subsidiaries |
|
|
263 |
|
|
1,052 |
|
|
|
— |
|
|
1,315 |
|
|
|
— |
Expenses to unconsolidated subsidiaries, net |
|
|
437 |
|
|
272 |
|
|
|
— |
|
|
709 |
|
|
|
— |
Reorganization items |
|
|
878 |
|
|
1,003 |
|
|
|
13,477 |
|
|
1,881 |
|
|
|
25,509 |
Adjusted EBITDA |
|
$ |
15,596 |
|
$ |
4,255 |
|
|
$ |
(2,508) |
|
$ |
19,851 |
|
|
$ |
(1,404) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20190812005623/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
